ReleaseWire Connect

Psoriasis is a chronic, inflammatory disease triggered by deregulated Thymus-derived (T) cells, resulting inflammation and benign hyperplasia of keratinocytes within the skin. Manifestations of affected skin are red, thickened plaques with an overlying silver-white scale, which significantly impairs the patient’s physical and mental wellbeing. The primary cause of psoriasis is unknown, as are the mechanisms that lead to immune cells directing inflammatory responses towards the skin. Within the lucrative autoimmune market, the psoriasis market has grown considerably due to the repositioning of all three marketed Tumor Necrosis Factor (TNF) inhibitors: Humira (adalimumab) and Enbrel (etanercept) which were originally approved for rheumatoid arthritis, and also Remicade (infliximab), the first biologic to be approved for Crohn’s disease, an autoimmune disease which largely affects the gastrointestinal system.

Most up-to-date Research on "Jazz Pharmaceuticals plc - Product Pipeline Review - 2014" to its huge collection of research reports.

Most up-to-date Research on "Dendreon Corporation - Product Pipeline Review - 2014" to its huge collection of research reports.

Most up-to-date Research on "Wellstat Vaccines, LLC - Product Pipeline Review - 2014" to its huge collection of research reports.

Umbilical cord blood banking or cord blood banking is the practice of preserving blood from the umbilical cord for future use. Such preserved cord blood is used in medical therapies in similar fashion as that of stem cells derived from bone marrow. Cord blood banking is practiced for using the cord blood stem cells for the purpose or re-populating blood and treating various medical conditions. This report studies the current market condition and future potential for cord blood banking services.

Global and Chinese Sulbactam Acid (CAS 68373-14-8) Industry, 2009-2019 Market Research Report is a professional and in-depth market survey on Global and Chinese Sulbactam Acid (CAS 68373-14-8) industry. The report firstly reviews the basic information of Sulbactam Acid (CAS 68373-14-8) including its classification, application and manufacturing technology; The report then explores global and Chinas top manufacturers of Sulbactam Acid (CAS 68373-14-8) listing their product specification, capacity, production value, cost, gross margin and market share etc.;

Most up-to-date Research on "Vernalis plc - Product Pipeline Review - 2014" to its huge collection of research reports.

Most up-to-date Research on "Ambit Biosciences Corporation - Product Pipeline Review - 2014" to its huge collection of research reports.

Most up-to-date Research on "Wellstat Biologics Corporation - Product Pipeline Review - 2014" to its huge collection of research reports.

This report covers the market analysis of the multiplexed diagnostics technologies namely, very high, high, medium, low density multiplexed assays & next-generation sequencing. This report contains qualitative information about oligonucleotide arrays, phage display, bacterial artificial chromosome arrays, protein arrays, bead-based arrays, antibody arrays, reverse arrays, mass spectrometry, quantitative PCR bead-based and microplate assays and next-generation sequencing. Further this market is also segmented on the basis of several application areas of multiplexed diagnostics, namely, infectious disease diagnosis, oncology, autoimmune diseases, cardiac conditions, allergies and others (Alzheimer’s disease, diabetes, kidney toxicity and HIV). The global multiplexed diagnostics market has phenomenally increased the volume and quality of diagnostic procedures by reducing the turnaround time and analyzing multiple analytes in a single cycle and thereby resulting in rapid adoption of such techniques. The stake holders in this market include market players who provide multiplexed diagnostic assay kits, reagents, solutions and systems.